Revolution Medicines drug Rasonoque shows promise against lung cancer

Name: Revolution Medicines drug Rasonoque shows promise against lung cancer
Uploaded: 2026-09-05T00:00:06Z
Duration: 2 min 33 s
Description: Revolution Medicines CEO Dr. Mark Goldsmith discusses the FDA approval of Rasonoque for metastatic pancreatic cancer and new clinical trial results showing its potential in treating advanced lung cancer.

FBN’s Wall Street · FBN · Aired Yesterday · 2m 33s

Watch Now

Already a subscriber?

Revolution Medicines CEO Dr. Mark Goldsmith discusses the FDA approval of Rasonoque for metastatic pancreatic cancer and new clinical trial results showing its potential in treating advanced lung cancer.